The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,239.95 Delivery Order contract to Organogenesis Inc., a leading regenerative medicine company, for the supply of APLIGRAF, a specialized wound care product. The contract has a fixed price with economic price adjustment pricing type and an ultimate completion date of December 27, 2024. This award is part of Organogenesis' larger federal contract vehicles, including a $25 million single-award Indefinite Delivery Contract...
This federal contract award, valued at $3,719.85, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The contract is a delivery order for the medical product APLIGRAF, a skin substitute. This award is part of Organogenesis' larger federal contract vehicles, including a $25 million Indefinite Delivery Contract with the Department of Veterans Affairs (VA) for surgical implants, a $30 million...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The $1,239.95 fixed-price delivery order is for the supply of APLIGRAF, a skin substitute product, to support wound care and tissue regeneration for military personnel and veterans. Organogenesis is an established vendor for the Department of Veterans Affairs (VA) and DLA, holding several significant federal...
This federal contract award, valued at $2,479.90, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The award is a delivery order contract for the APLIGRAF product, which is a specialized skin substitute and wound matrix used in medical treatments. Organogenesis has a robust presence in government medical procurement,...
This federal contract award to Organogenesis Inc., a leading regenerative medicine company, is for the delivery of APLIGRAF, a wound care product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,239.95 fixed-price delivery order, which includes an economic price adjustment, has a completion date of June 11, 2024. Organogenesis Inc. is a for-profit manufacturer of goods and has been a registered federal contractor since 2006. The company holds several significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading manufacturer of regenerative medicine products. The order, valued at $1,239.95, is for the company's APLIGRAF skin substitute product. The order is a fixed-price contract with economic price adjustment, and does not utilize a set-aside designation. Organogenesis Inc. is a long-standing federal contractor, providing a range of wound care and surgical biologics to the...
This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The contract is a delivery order for the company's APLIGRAF product, a skin substitute used in advanced wound care. The award is part of a larger $183.15 million multiple-award Indefinite Delivery Contract (IDC) the DLA awarded to Organogenesis and other suppliers for medical and surgical supplies under the...
This is a federal contract award to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the delivery of APLIGRAF, a skin substitute product. The contract is a Delivery Order, with a Ceiling Value of $1,239.95, and a Fixed Price with Economic Price Adjustment pricing type. The contract has an Ultimate Completion Date of April 17, 2025. Organogenesis Inc. is a for-profit...
This federal contract award is for a delivery order (SPE2DE21D0005|SPE2D625F52FT) with a ceiling value of $1,239.95, issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit medical manufacturer headquartered in Canton, Massachusetts. The contract is for the supply of APLIGRAF, a skin substitute product, to support wound care and tissue regeneration needs across military and veteran healthcare systems. Organogenesis holds several...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The $1,239.95 firm-fixed-price delivery order, awarded on December 18, 2024, is for the supply of APLIGRAF, a regenerative skin substitute product. The award is not associated with a set-aside program and is part of Organogenesis' broader...